Nebulized amphotericin B does not improve exacerbation-free status at 1 year for patients with bronchopulmonary aspergillosis, though it may delay onset and incidence. Investigators searched PubMed ...
Amphotericin B vs itraconazole for HIV-associated talaromycosis Treatment with amphotericin B was superior to itraconazole as an induction therapy for HIV-associated talaromycosis. Treatment with the ...
EFFECTIVE therapy for most of the deep mycoses has not been available until recently. With the exceptions of iodides for sporotrichosis, penicillin for actinomycosis, sulfadiazine for nocardiosis and ...
These findings support the safety and use of single high-dose liposomal amphotericin B over alternative treatment options. For patients with HIV-associated fungal infections, single high-dose ...
An antifungal small molecule drug could restore some of the function lost in cystic fibrosis. Cystic fibrosis is a disease caused by mutations in the cystic fibrosis transmembrane conductance ...
PURPOSE: In a randomized, double-blind, comparative, multicenter trial, liposomal amphotericin B was equivalent to conventional amphotericin B for empirical antifungal therapy in febrile neutropenic ...
The Food and Drug Administration (FDA) has granted Orphan Drug designation to MAT2203 (Matinas BioPharma) for the treatment of cryptococcosis. The Food and Drug Administration (FDA) has granted Orphan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results